Prognostic value of S-Phase Fraction in T3N0M0 gastric cancer. Implications for adjuvant chemotherapy

Anticancer Research

Volumn 20, Issue 5 C, 2000, Pages 3839-3842

  Cascinu, S ^a   Graziano, F ^a   Catalano, V ^a   Valentini, M ^a   Rossi, M C ^a   Baldelli, A M ^a   Ghiselli, R ^a   Saba, V ^a   Giordani, P ^a   Catalano, G ^a  

^a Ospedale di Muraglia   (Italy)

Author keywords

Gastric cancer; Prognosis adjuvant chemotherapy; S phase fraction

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE S PHASE; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; S PHASE; STOMACH NEOPLASMS; SURVIVAL RATE; TIME FACTORS;

EID: 0034529349     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Tabular analysis of 10,000 cases of gastric cancer
2. Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials
3. Adjuvant chemotherapy after curative resection for gastric cancer in non-asian patients: Revisiting a meta-analysis of randomized trials
4. Gastric cancer therapy: A translational research paradigm
5. Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study
6. DNA flow cytometry of stomach cancer. Prospective correlation with clinicopathologic findings
7. Significance of cell proliferation measurements in gastric cancer
8. S-phase fraction and malignant potential in DNA diploid colorectal cancer
9. Prediction of early and late recurrence after curative resection for gastric carcinoma
10. Recurrence following curative resection for gastric carcinoma
11. Cell kinetics and DNA distribution pattern determined by flow cytometry in early and advanced gastric cancer
12. Flow cytometry as a predictive indicator in patients with operable cancer
13. Flow cytometric analysis of nuclear DNA content in advanced gastric cancer and its relationship with prognosis
14. Ki- 67, ploidy and S-phase fraction as prognostic factors in gastric cancer
15. Comparison of DNA ploidy and S-phase fiaction with prognostic factors in gastric cancer
16. Prognostic value of DNA flow cytometry in stomach cancer: A 5-year prospective study
17. Prognostic significance of DNA ploidy, S-phase fraction and tissue levels of aspartic, cysteine and serine protease in operable gastric carcinoma
18. DNA content by flow cytometry in gastric carcinoma: Pathology, ploidy and prognosis
19. Flow cytometric DNA ploidy p53 PCNA and c-erbB- 2 protein expressions as predictors of survival in surgically resected gastric cancer patients
20. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer. A randomised trial
21. Recurrences and relation to tumor growth potential and local immune response in node-negative advanced gastric cancer
22. Growth fractions in gastric carcinomas determined with monoclonal antibody Ki-67
23. Clinical relevance of pS3 index, and expression of proliferting cell nuclear antigen and Ki- 67 in gastric cancer
24. Immunohistochemical study on the prognostic value of MIB- 1 in gastric cancer
25. Analysis of proliferative activity using anti-proliferating cell nuclear antigen antibody in gastric cancer tissue specimen obtained by endoscopic biopsy
26. Prognostic value of tumor cell proliferation and intratumor microvessel density in advanced gastric cancer treated with curative surgery
27. Prognostic significance of different biological markers (DNA index, PCNA index, apoptosis, pS3, karyotype) in 126 adenocarcinoma gastric biopsies